AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Sugaray M 50mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Lloyd Healthcare Pvt Ltd

Salt Composition

Sitagliptin (50mg) + Metformin (500mg)

Overview Sugaray M 50mg/500mg Tablet

Diabetol Duo 50mg/500mg tablets combine two medications to manage elevated blood glucose in type 2 diabetes. This dual action helps prevent severe diabetic complications like vision impairment and kidney disease, potentially lessening heart attack and stroke risks. Diabetol Duo may be used independently or alongside other diabetes treatments. Optimal results require adherence to a balanced diet and regular physical activity. Dosage is tailored to individual health status, blood sugar readings, and other medications. Consuming it with meals minimizes stomach upset. Consistent daily intake at the same time maximizes effectiveness; discontinuation should only occur under medical supervision. Maintaining the prescribed diet and exercise plan is crucial for successful diabetes management, as lifestyle significantly impacts blood sugar control. Common side effects include nausea, vomiting, diarrhea, headache, stomach discomfort, and sore throat. Low blood sugar (hypoglycemia) is a possible side effect, especially when combined with insulin or sulfonylureas; learn to identify and manage this risk. This medication isn't suitable for everyone. Inform your doctor of any prior kidney, liver, heart, or pancreatic issues, or significant alcohol consumption before starting treatment. Pregnant or breastfeeding individuals require medical consultation. Interactions with other medications are possible; disclose all current medications to your doctor to ensure safety. Alcohol should be limited due to its potential to lower blood glucose. Your physician will monitor kidney function and blood sugar levels throughout treatment.

Uses of Sugaray M 50mg/500mg Tablet

Managing type 2 diabetes

Major Benefits of Sugaray M 50mg/500mg Tablet:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the Sugaray M 50mg/500mg Tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with food.

Common Side effects of Sugaray M 50mg/500mg Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Sugaray M 50mg/500mg Tablet:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the Sugaray M 50mg/500mg tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.

How Sugaray M 50mg/500mg Tablet works:

Sugaray M, a 50mg/500mg tablet, combines sitagliptin and metformin to manage blood glucose levels. Sitagliptin boosts insulin production by the pancreas, enhances insulin utilization, and diminishes hepatic glucose output. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and improves insulin sensitivity. This dual action results in improved glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Sugaray M 50mg/500mg Tablet is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Sugaray M 50mg/500mg tablets during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to the fetus. A physician will assess the potential benefits against any risks before prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Sugaray M 50mg/500mg tablets while breastfeeding is likely inadvisable. Preliminary human data indicate potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Sugaray M 50mg/500mg tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates use. Consult your physician. Kidney function should be regularly monitored during treatment.

LiverLiverUNSAFE

Patients with liver impairment should likely avoid Sugaray M 50mg/500mg Tablets due to potential safety concerns. Medical advice is recommended.

What if you forget to take Sugaray M 50mg/500mg Tablet :

Should you forget a Sugaray M 50mg/500mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Sugaray M 50mg/500mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Sugaray M 50mg/500mg Tablet

Sugaray M 50mg/500mg tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Prolonged use of Sugaray M 50mg/500mg tablets can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and urinary issues), and cognitive changes (including balance problems). To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Sugaray M 50mg/500mg tablets may cause common side effects including low blood sugar, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects such as lactic acidosis are also possible. Prolonged use may result in vitamin B12 deficiency.
Sugaray M 50mg/500mg Tablets are contraindicated in patients with allergies to any ingredient or excipient. Avoid use in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sugaray M 50mg/500mg tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Store this medication in its original, tightly closed container as directed on the label or packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Sugaray M 50mg/500mg Tablets can cause lactic acidosis (MALA, or Metformin-associated lactic acidosis), a serious medical emergency resulting from excess lactic acid in the bloodstream. This rare side effect necessitates caution in patients with kidney disease, the elderly, or those who consume significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Sugaray M 50mg/500mg tablets combine sitagliptin and metformin to treat type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Sugaray M 50mg/500mg tablets may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Sugaray M 50mg/500mg Tablets are contraindicated in patients with known allergies to any ingredient or excipient. Avoid use in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sugaray M 50mg/500mg tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Sugaray M 50mg/500mg Tablets can cause lactic acidosis (MALA, or Metformin-associated lactic acidosis), a serious medical emergency resulting from excessive blood lactic acid. This rare side effect necessitates avoiding the medication in patients with kidney disease, the elderly, or those consuming significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Prolonged use of Sugaray M 50mg/500mg tablets can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left unaddressed. To mitigate this risk, supplemental vitamin B12 intake at least annually is recommended by some researchers.
Store this medication in its original, tightly closed container, as directed on the label. Discard any unused medication. Keep it out of reach of children, pets, and others.
Sugaray M 50mg/500mg tablets combine sitagliptin and metformin to treat type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Sugaray M 50mg/500mg tablets may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Sugaray M 50mg/500mg Tablets are contraindicated in patients with known allergies to any ingredient or excipient. Avoid use in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sugaray M 50mg/500mg tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Sugaray M 50mg/500mg Tablets can cause lactic acidosis (MALA – Metformin-associated lactic acidosis), a serious medical emergency resulting from excess lactic acid in the blood. This rare side effect necessitates avoiding use in patients with kidney disease, the elderly, or those consuming significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Prolonged use of Sugaray M 50mg/500mg tablets can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency may cause anemia, neurological issues such as numbness and tingling in the extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate these risks, supplemental vitamin B12 intake at least annually is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Sugaray M 50mg/500mg Tabl...
141
MRP 163
13% off